Skip to content

Delcath Systems DCTH Return on invested capital

Return on invested capital at other companies

Merit Medical Systems logo
Merit Medical SystemsMMSI
7.4%-0.2pp
Boston Scientific logo
Boston ScientificBSX
10.9%+4.0pp
Altimmune logo
AltimmuneALT
-61.7%-17.9pp
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
-43.3%
Immunome logo
ImmunomeIMNM
-746.6%+212pp
Arcus Biosciences logo
Arcus BiosciencesRCUS
-95.3%+1.8pp

Other financials

Income statement

See full
Revenue$25.0M+26.3%
Gross profit$21.3M+25.5%
Operating income-$1.6M-355%
Net income-$1.1M-200%
EPS (diluted)-$0.03-200%

Balance sheet

See full
Cash & equivalents$41.3M+223%
Total debt$907.0K-10.7%
Total equity$112.7M+40.5%
Total assets$124.8M+43.0%

Cash flow

See full
Operating cash flow$857.0K-61.1%
CapEx$570.0K+307%
Free cash flow$287.0K-86.1%

Valuation

See full
Market cap$425.31M-11.8%
Enterprise value$384.91M-18.2%
P/E120.6×
P/S4.7×-4.3×

Profitability

See full
Gross margin86%+1.1pp
Operating margin-118.1%-56.8pp
Net margin1.5%+0.8pp
FCF margin21.2%+15.2pp

Returns & leverage

See full
Return on equity1.9%+1.0pp
Debt / equity0.0×
Current ratio11.2×-4.7×

Where this comes from

Calculated from Delcath Systems’s reported figures.

Based on trailing twelve months.

The official record: Delcath Systems’s 10-Q, filed November 4, 2025, on SEC EDGAR. View the filing →

Ask your AI about Delcath Systems's return on invested capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Delcath Systems's return on invested capital?
Delcath Systems (DCTH) reported return on invested capital of -0.6% in Q3 2025.
What does return on invested capital mean?
Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.